arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Heartflow, Inc.

HTFL
$50.15 ▼ -0.23 (-0.46%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
12 Visible periods
26 Metrics
Peer-ranked Benchmarks
Price Chart
21
Health
Poor
Bearish
auto_awesome

Analytical Summary

Heartflow, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $4.3B
Dividend Yield
Revenue Growth 47.6%
Op. Margin -27.9%
ROIC -6.4%
FCF / Share $-0.12
Trailing P/E
Price / Book 15.6x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 22, 2026.

12-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$64.08M
↑ +47.6%
Net Income Profit after all expenses
$-27.38M
↑ +15.4%
Operating Margin Operating profit as % of sales
-27.9%
↑ +50.2% 7th
FCF / Share Free cash flow per share
$-0.12
↑ +97.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
6
Returns
20
Financial Health
33
Cash Quality
40

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 4 years · 12 quarters